Pharmaceutical Sciences Laboratory

The research group of Biomaterials and Drug Fabrication (BDF) was established in 2020 in integration with the Research Group of Pharmaceutical Printing that was founded by Prof. Niklas Sandler (2009-2020). The BDF research group has a goal to provide novel biomaterials and drug delivery systems to biomedical and pharmaceutical fields with a particularly focus engaging natural polymers, nanocomposites, application of advanced fabrication tools such as 3D (bio)printing.  

A research interest of BDF group is on developing chemistry and material approaches to engineer high-performance natural material-based bioinks for 3D bioprinting in service of fabrication of cell culture platforms and tissue mimics. The major catalogue of natural materials include but not limited to biomass-derived biopolymers and lignocellulosic nanomaterials. The BDF group builds up its expertise in several areas by exploiting different disciplines and they are referred to biopolymers for biomaterials, cellulosic nanomaterials in constructing biomedical hydrogels, bioceramics and their composite materials, additive fabrication technology such as 3D (bio)printing for both constructing in vitro biomedical models and fabricating drug delivery systems.

An important aspect is the development and research of characterization tools in terms of nano-scaled morphology and rheology of novel biomaterials that are crucial for understanding of the material characteristics and correlation mechanism with their applications. The group is part of the BioCity Biomaterials and Medical Devices Research program. The BDF group is also in close collaboration with Laboratory of Natural Materials Technology, ÅAU.